SIB-1757 6-METHYL-2-(PHENYLAZO)-3-PYRIDINOL - Names and Identifiers
SIB-1757 6-METHYL-2-(PHENYLAZO)-3-PYRIDINOL - Physico-chemical Properties
Molecular Formula | C12H11N3O
|
Molar Mass | 213.24 |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | crystalline |
Color | red |
Storage Condition | Store at RT |
SIB-1757 6-METHYL-2-(PHENYLAZO)-3-PYRIDINOL - Risk and Safety
Hazard Symbols | Xi - Irritant
|
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin.
|
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36 - Wear suitable protective clothing.
|
WGK Germany | 3 |
SIB-1757 6-METHYL-2-(PHENYLAZO)-3-PYRIDINOL - Introduction
SIB 1757 (also known as methyl 2-amino-3-pyridinecarboxylate tosamide) is an organic compound with the chemical formula C12H12N2O3S. SIB 1757 is a white crystalline solid, soluble in some organic solvents, such as ethanol and dimethylformamide.
SIB 1757 are usually used as intermediates in drug synthesis, especially in the preparation of drugs containing amino acids or pyridine structures. It has also shown some potential applications in some medical fields, such as as leading compounds of analgesic drugs and anti-tumor drugs.
A common method for preparing SIB 1757 is to react 2-amino -3-pyridine carboxylic acid with methyl formate, which is generated under base catalysis. This reaction is generally carried out at room temperature for a relatively short reaction time.
Regarding safety information, SIB 1757 is an organic compound, and few studies have been reported on its specific toxicity and safety. However, as a chemical substance, care should be taken to prevent contact with eyes, skin and inhalation. Wear appropriate personal protective equipment such as gloves, goggles and protective clothing when operating. Use and handle properly during use and storage, and follow relevant laboratory safety procedures. If ingested or inhaled by mistake, seek medical attention immediately and provide the details of the compound to the doctor.
Last Update:2024-04-09 20:45:29